-- RESEARCH ALERT-Impax Laboratories: UBS raises price target
-- 
-- Tue Jan 21, 2014 12:14PM EST
-- None



Jan 21 (Reuters) -  * Impax Laboratories Inc <IPXL.O> : UBS raises price target to $26 from $21;    rating neutral  * Eli Lilly and Co <LLY.N> : UBS raises price target to $55 from $50; rating    neutral  * Mylan Inc <MYL.O> : UBS raises price target to $52 from $46; rating buy  * Perrigo Company Plc <PRGO.N> : UBS raises price target to $176 from $160;    rating buy  For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on RCH/US Reuters 3000Xtra users, double-click RCH/US Thomson ONE users, type in RT/RCH/US  For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on RCH/CA Reuters 3000Xtra users, double-click RCH/CA Thomson ONE users, type in RT/RCH/CA  ((nyc.equities.newsroom@reuters.com); (Reuters Messaging: saqib.ahmed.thomsonreuters.com@reuters.net) ((Bangalore Newsroom +91 80 6749 1130; within U.S. +1 646 223 8780))

